Rizatriptan Benzoate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 76420-908
  • Package NDC 76420-908-18
  • Application number ANDA203062
  • SPL ID 2cb4448b-6604-9be4-e063-6394a90a1b6d
  • SPL set ID 8fa794f4-4253-485d-b4ee-986178031339
  • UNII WR978S7QHH
  • RxCUI 312837
  • RxCUI 312839

What the source publishes

Labeler
Asclemed USA, Inc.
Active ingredients
Rizatriptan Benzoate
Form
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:76420-908_2cb4448b-6604-9be4-e063-6394a90a1b6d
{
  "name": "Rizatriptan Benzoate",
  "splId": "2cb4448b-6604-9be4-e063-6394a90a1b6d",
  "labels": [
    {
      "setId": "8fa794f4-4253-485d-b4ee-986178031339",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8fa794f4-4253-485d-b4ee-986178031339",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8fa794f4-4253-485d-b4ee-986178031339"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Asclemed USA, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "3 BLISTER PACK in 1 CARTON (76420-908-18)  / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
      "package_ndc": "76420-908-18",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250127"
    }
  ],
  "productId": "76420-908_2cb4448b-6604-9be4-e063-6394a90a1b6d",
  "useDomain": "unknown",
  "dosageForm": "TABLET, ORALLY DISINTEGRATING",
  "productNdc": "76420-908",
  "deaSchedule": null,
  "genericName": "Rizatriptan Benzoate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RIZATRIPTAN BENZOATE",
      "strength": "5 mg/1"
    }
  ],
  "applicationNumber": "ANDA203062",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20130701",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "WR978S7QHH"
    ],
    "rxcui": [
      "312837",
      "312839"
    ],
    "spl_set_id": [
      "8fa794f4-4253-485d-b4ee-986178031339"
    ],
    "manufacturer_name": [
      "Asclemed USA, Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:76420-908_2cb4448b-6604-9be4-e063-6394a90a1b6d"